The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:
linktr.ee/DivergenceSeeker
linktr.ee/DivergenceSeeker
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:
linktr.ee/DivergenceSeeker
linktr.ee/DivergenceSeeker
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.